These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 24486602)

  • 41. c-Yes enhances tumor migration and invasion via PI3K/AKT pathway in epithelial ovarian cancer.
    Jin Y; Huang M; Wang Y; Yi C; Deng Y; Chen Y; Jiang L; Wang J; Shen Q; Liu R; QinghuaXi
    Exp Mol Pathol; 2016 Aug; 101(1):50-7. PubMed ID: 27289010
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Elevated expression of MAC30 predicts lymph node metastasis and unfavorable prognosis in patients with epithelial ovarian cancer.
    Yang S; Li H; Liu Y; Ning X; Meng F; Xiao M; Wang D; Lou G; Zhang Y
    Med Oncol; 2013 Mar; 30(1):324. PubMed ID: 23254963
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Glia maturation factor-gamma is preferentially expressed in microvascular endothelial and inflammatory cells and modulates actin cytoskeleton reorganization.
    Ikeda K; Kundu RK; Ikeda S; Kobara M; Matsubara H; Quertermous T
    Circ Res; 2006 Aug; 99(4):424-33. PubMed ID: 16873721
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Defective expression of Protein 4.1N is correlated to tumor progression, aggressive behaviors and chemotherapy resistance in epithelial ovarian cancer.
    Xi C; Ren C; Hu A; Lin J; Yao Q; Wang Y; Gao Z; An X; Liu C
    Gynecol Oncol; 2013 Dec; 131(3):764-71. PubMed ID: 23994105
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CKS2 promotes tumor progression and metastasis and is an independent predictor of poor prognosis in epithelial ovarian cancer.
    Xu JH; Wang Y; Xu D
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3225-3234. PubMed ID: 31081074
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of Cyclin G1 in cellular proliferation and apoptosis of human epithelial ovarian cancer.
    Jiang L; Liu R; Wang Y; Li C; Xi Q; Zhong J; Liu J; Yang S; Wang J; Huang M; Tang C; Fang Z
    J Mol Histol; 2015 Jun; 46(3):291-302. PubMed ID: 25981880
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Overexpression of tumor necrosis factor receptor-associated protein 1 (TRAP1) are associated with poor prognosis of epithelial ovarian cancer.
    Lv Q; Sun H; Cao C; Gao B; Qi Y
    Tumour Biol; 2016 Feb; 37(2):2721-7. PubMed ID: 26408177
    [TBL] [Abstract][Full Text] [Related]  

  • 48. EIF5A1 promotes epithelial ovarian cancer proliferation and progression.
    Zhang J; Li X; Liu X; Tian F; Zeng W; Xi X; Lin Y
    Biomed Pharmacother; 2018 Apr; 100():168-175. PubMed ID: 29428664
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sam68 is Overexpressed in Epithelial Ovarian Cancer and Promotes Tumor Cell Proliferation.
    Dong L; Che H; Li M; Li X
    Med Sci Monit; 2016 Sep; 22():3248-56. PubMed ID: 27623016
    [TBL] [Abstract][Full Text] [Related]  

  • 50. NEDD9 overexpression is associated with the progression of and an unfavorable prognosis in epithelial ovarian cancer.
    Wang H; Mu X; Zhou S; Zhang J; Dai J; Tang L; Xiao L; Duan Z; Jia L; Chen S
    Hum Pathol; 2014 Feb; 45(2):401-8. PubMed ID: 24439227
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MicroRNA-145 targets TRIM2 and exerts tumor-suppressing functions in epithelial ovarian cancer.
    Chen X; Dong C; Law PT; Chan MT; Su Z; Wang S; Wu WK; Xu H
    Gynecol Oncol; 2015 Dec; 139(3):513-9. PubMed ID: 26472353
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MiR-205 promotes motility of ovarian cancer cells via targeting ZEB1.
    Niu K; Shen W; Zhang Y; Zhao Y; Lu Y
    Gene; 2015 Dec; 574(2):330-6. PubMed ID: 26275944
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MUC20 promotes aggressive phenotypes of epithelial ovarian cancer cells via activation of the integrin β1 pathway.
    Chen CH; Shyu MK; Wang SW; Chou CH; Huang MJ; Lin TC; Chen ST; Lin HH; Huang MC
    Gynecol Oncol; 2016 Jan; 140(1):131-7. PubMed ID: 26616226
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rac1 expression in epithelial ovarian cancer: effect on cell EMT and clinical outcome.
    Leng R; Liao G; Wang H; Kuang J; Tang L
    Med Oncol; 2015 Feb; 32(2):329. PubMed ID: 25585684
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Malignant ascites enhances migratory and invasive properties of ovarian cancer cells with membrane bound IL-6R in vitro.
    Kim S; Gwak H; Kim HS; Kim B; Dhanasekaran DN; Song YS
    Oncotarget; 2016 Dec; 7(50):83148-83159. PubMed ID: 27825119
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MicroRNA-222-3p/GNAI2/AKT axis inhibits epithelial ovarian cancer cell growth and associates with good overall survival.
    Fu X; Li Y; Alvero A; Li J; Wu Q; Xiao Q; Peng Y; Hu Y; Li X; Yan W; Guo K; Zhou W; Wang Y; Liu J; Zhang Y; Mor G; Wen J; Yin G
    Oncotarget; 2016 Dec; 7(49):80633-80654. PubMed ID: 27811362
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Downregulation of microRNA-630 inhibits cell proliferation and invasion and enhances chemosensitivity in human ovarian carcinoma.
    Zou YT; Gao JY; Wang HL; Wang Y; Wang H; Li PL
    Genet Mol Res; 2015 Jul; 14(3):8766-77. PubMed ID: 26345808
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MicroRNA‑139 suppressed tumor cell proliferation, migration and invasion by directly targeting HDGF in epithelial ovarian cancer.
    Liu J; Jin S; Wang R
    Mol Med Rep; 2017 Sep; 16(3):3379-3386. PubMed ID: 28713954
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stomatin-like protein 2 is overexpressed in epithelial ovarian cancer and predicts poor patient survival.
    Sun F; Ding W; He JH; Wang XJ; Ma ZB; Li YF
    BMC Cancer; 2015 Oct; 15():746. PubMed ID: 26487491
    [TBL] [Abstract][Full Text] [Related]  

  • 60. BCAT1 expression associates with ovarian cancer progression: possible implications in altered disease metabolism.
    Wang ZQ; Faddaoui A; Bachvarova M; Plante M; Gregoire J; Renaud MC; Sebastianelli A; Guillemette C; Gobeil S; Macdonald E; Vanderhyden B; Bachvarov D
    Oncotarget; 2015 Oct; 6(31):31522-43. PubMed ID: 26372729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.